Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

Perumal D1,2, Imai N1,2, Laganà A3,4, Finnigan J1,2,5, Melnekoff D3,4, Leshchenko VV1,2, Solovyov A5,6,7, Madduri D1,2, Chari A1,2, Cho HJ1,2, Dudley JT3,4, Brody JD1,2,5, Jagannath S1,2, Greenbaum B5,6,7, Gnjatic S2,5, Bhardwaj N1,2,5, Parekh S8,2. Author information 1 Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. 2 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 3 Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. 4 Institute for Next Generation Healthcare, Icahn School of Medicine at Mount Sinai, New York, New York. 5 Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 6 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. 7 Center for Computational Immunology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 8 Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York. samir.parekh@mssm.edu.